Daunorubicin Cancer Research Results

DNR, Daunorubicin: Click to Expand ⟱
Features: Chemotherapy Drug

Daunorubicin - Anthracycline Chemotherapy

Recommended Abbreviation: DNR

Alternative Names: Daunomycin, Daunorubicin

Type: Anthracycline antibiotic / topoisomerase II inhibitor / chemotherapy drug

Function: Daunorubicin intercalates into DNA and inhibits topoisomerase II, preventing normal DNA strand breakage and religation during replication and transcription. It also generates reactive oxygen species and contributes to DNA damage, mitochondrial injury, and apoptosis.

Cancer: Established anticancer drug used primarily in acute leukemias, including acute myeloid leukemia. Daunorubicin promotes DNA damage, topoisomerase II inhibition, oxidative stress, cell-cycle disruption, and apoptosis.
Scientific Papers found: Click to Expand⟱
Showing Research Papers: 0 to 0 of 0

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 0

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Total Targets: 0

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:472  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page